In vitro evaluation of a novel 2,6,9-trisubstituted purine acting as a cyclin-dependent kinase inhibitor

被引：4

作者：

Giocanti, N

Sadri, R

Legraverend, M

Ludwig, O

Bisagni, E

Leclerc, S

Meijer, L

Favaudon, V ^{[1
]}

机构：

[1] Ctr Univ, Rech Labs 110 112, Inst Curie, INSERM,U350, F-91405 Orsay, France

[2] Ctr Univ, Inst Curie, CNRS, UMR 176, F-91405 Orsay, France

[3] CNRS, UPR 9042, Biol Stn, F-20682 Roscoff, France

来源：

ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN | 1999年 / 886卷

关键词：

D O I：

10.1111/j.1749-6632.1999.tb09411.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：180 / 182

页数：3

共 10 条

[1]

Bartkova J, 1997, Prog Cell Cycle Res, V3, P211

[2] Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines [J].

BuquetFagot, C ;

Lallemand, F ;

Montagne, MN ;

Mester, J .

ANTI-CANCER DRUGS, 1997, 8 (06) :623-631

[3]

Carlson BA, 1996, CANCER RES, V56, P2973

[4] Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra [J].

Henchcliffe, C ;

Burke, RE .

NEUROSCIENCE LETTERS, 1997, 230 (01) :41-44

[5]

KITAGAWA M, 1993, ONCOGENE, V8, P2425

[6]

Maas JW, 1998, J NEUROCHEM, V70, P1401

[7]

Meijer L, 1997, METHOD ENZYMOL, V283, P113

[8] INHIBITION OF CYCLIN-DEPENDENT KINASES BY PURINE ANALOGS [J].

VESELY, J ;

HAVLICEK, L ;

STRNAD, M ;

BLOW, JJ ;

DONELLADEANA, A ;

PINNA, L ;

LETHAM, DS ;

KATO, J ;

DETIVAUD, L ;

LECLERC, S ;

MEIJER, L .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02) :771-786

[9]

WALKER DH, 1998, P AM ASSOC CANC RES, V39, P1678

[10] Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling [J].

Zhang, Q ;

Ahuja, HS ;

Zakeri, ZF ;

Wolgemuth, DJ .

DEVELOPMENTAL BIOLOGY, 1997, 183 (02) :222-233

← 1 →